Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study

Clinical Cardiology

Volumn 40, Issue 4, 2017, Pages 210-215

  Matsumoto, Suguru ^a   Ibrahim, Reda ^b   Grégoire, Jean C ^b   L'Allier, Philippe L ^b   Pressacco, Josephine ^b   Tardif, Jean Claude ^b   Budoff, Matthew J ^a  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

acute coronary syndromes; Clinical trials; computed tomography; Imaging; Ischemic heart disease

Indexed keywords

ATRELEUTON; PLACEBO; HYDROXYUREA; LIPOXYGENASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY PLAQUE; DENSE CALCIUM PLAQUE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FIBRO CALCIFIED PLAQUE; FIBRO FATTY TISSUE; HUMAN; LOW ATTENUATION PLAQUE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; ANALOGS AND DERIVATIVES; COMPLICATION; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; DOSE RESPONSE; FOLLOW UP; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PLAQUE, ATHEROSCLEROTIC; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; COMPUTED TOMOGRAPHY ANGIOGRAPHY; CORONARY VESSELS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; HYDROXYUREA; LIPOXYGENASE INHIBITORS; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 85006043190     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22646     Document Type: Article

References (18)

1. Stone GW, Maehara A, Lansky AJ, et al; PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis [published correction appears in N Engl J Med. 2011;365:2040]. N Engl J Med. 2011;364:226–235.
2. Spanbroek R, Grabner R, Lotzer K, et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci U S A. 2003;100:1238–1243.
3. Dwyer JH, Allayee H, Dwyer KM, et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med. 2004;350:29–37.
4. Bäck M. Inflammatory signaling through leukotriene receptors in atherosclerosis. Curr Atheroscler Rep. 2008;10:244–251.
5. Tardif JC, L'Allier PL, Ibrahim R, et al. Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome. Circ Cardiovasc Imaging. 2010;3:298–307.
6. Motoyama S, Kondo T, Anno H, et al. Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging. Circ J. 2007;71:363–366.
7. Raff GL, Abidov A, Achenbach S, et al; Society of Cardiovascular Computed Tomography. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr. 2009;3:122–136.
8. Nicholls SJ, Hsu A, Wolski K, et al. Intravascular ultrasound–derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol. 2010;55:2399–2407.
9. Hamirani YS, Zeb I, Pagali SR, et al. Normalization of automatic plaque quantification in cardiac computed tomography (CCT). Int J Cardiol. 2011;146:282–290.
10. Lehnigk B, Rabe KF, Dent G, et al. Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients. Eur Respir J. 1998;11:617–623.
11. Falk E, Nakano M, Bentzon JF, et al. Update on acute coronary syndromes: the pathologists’ view. Eur Heart J. 2013;34:719–728.
12. Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54:49–57.
13. Zeb I, Li D, Nasir K, et al. Effect of statin treatment on coronary plaque progression—a serial coronary CT angiography study. Atherosclerosis. 2013;231:198–204.
14. Papadopoulou SL, Neefjes LA, Garcia-Garcia HM, et al. Natural history of coronary atherosclerosis by multislice computed tomography. JACC Cardiovasc Imaging. 2012;(3 suppl):S28–S37.
15. Inoue K, Motoyama S, Sarai M, et al. Serial coronary CT angiography–verified changes in plaque characteristics as an endpoint: evaluation of effect of statin intervention. JACC Cardiovasc Imaging. 2010;3:691–698.
16. Gaztanaga J, Farkouh M, Rudd JH, et al. A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome. Atherosclerosis. 2015;240:53–60.
17. Matsumoto S, Nakanishi R, Li D, et al. Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with metabolic syndrome in a prospective randomized double-blind study. J Nutr. 2016;146:427S–432S.
18. Papadopoulou SL, Garcia-Garcia HM, Rossi A, et al. Reproducibility of computed tomography angiography data analysis using semiautomated plaque quantification software: implications for the design of longitudinal studies. Int J Cardiovasc Imaging. 2013;29:1095–1104.